Managing actinic keratoses with retinoids.
Odom
R
R
Department of Dermatology, University of California, San Francisco 94143, USA.
D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005050:Etretinate / Q000627:therapeutic use; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D007641:Keratolytic Agents / Q000627:therapeutic use; D007642:Keratosis / Q000188:drug therapy*; D009637:Masoprocol / Q000627:therapeutic use; D009381:Neoplasms, Radiation-Induced / Q000188:drug therapy; D012176:Retinoids / Q000627:therapeutic use*; D012878:Skin Neoplasms / Q000188:drug therapy*; D014212:Tretinoin / Q000627:therapeutic use
D000964:Antimetabolites, Antineoplastic; D007641:Keratolytic Agents; D012176:Retinoids; D014212:Tretinoin; D005050:Etretinate; D009637:Masoprocol; D005472:Fluorouracil